▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4017 by analyst upside · 2026-06-27
DVA
DaVita Inc.
Healthcare · Market Cap $14B · P/E 20.5x
ANALYST PRICE TARGET
-10.7%
implied upside to consensus target
Current Price $217.04
Consensus Target $193.71
Bull Target $235.0
Bear Target $145.0
Analysts Covering 7
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
1
Hold
5
Sell
1
52-Week Low $101.0
52-Week High $217.04
YTD Return +89.5%
FUNDAMENTALS
Market Cap $14B
P/E Ratio (TTM) 20.5x
Forward P/E 12.6x
EPS (TTM) $10.57
PEG Ratio 0.66
Dividend Yield N/A
Revenue (TTM) $13.8B
Profit Margin 5.6%
52-WEEK RANGE
52-Week Low $101.0
52-Week High $217.04
Current Price $217.04
Bear Target $145.0
Bull Target $235.0
● Now $217.04 ● Target $193.71
TRADING DATA
Avg Volume 834K
YTD Return +89.5%
Analyst Count 7
Consensus Hold
Upside to Target -10.7%
Last Updated 2026-06-27

ANALYST SUMMARY

DaVita Inc. (DVA) is currently trading at $217.04 with a Wall Street consensus price target of $193.71, which is 10.7% below the current price over the next 12 months. 7 analysts currently cover DVA, with a consensus rating of Hold - 14% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $235.0, while the most cautious has a target of $145.0.

DVA operates in the Healthcare sector with a market capitalisation of $14B. The stock is up 89.5% year-to-date and is currently trading near the upper end of its 52-week range of $101.0 – $217.04.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

EXEL -9.6%
Exelixis, Inc.
$14B · P/E 18.1x · Buy
RDY -6.9%
Dr. Reddy's Laboratories Limited
$13B · P/E 28.5x · Hold
MEDP -15.9%
Medpace Holdings, Inc.
$15B · P/E 33.1x · Hold
SOLV +3.3%
Solventum Corporation
$14B · P/E 9.5x · Hold
FMS +9.2%
Fresenius Medical Care AG
$12B · P/E 12.5x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for DVA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen — Reiterated
Hold → Hold 2026-05-11 Building track record
Truist Securities — Reiterated
Hold → Hold 2026-05-08 Building track record
Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-05-08 Building track record
UBS — Reiterated
Buy → Buy 2026-05-07 33% win rate (6 calls)
Deutsche Bank ↑ Upgrade
Hold → Buy 2026-05-06 Building track record
UBS — Reiterated
Buy → Buy 2026-02-04 33% win rate (6 calls)
Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-02-03 Building track record
TD Cowen — Reiterated
Hold → Hold 2025-11-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
16/30
Consensus clarity
22/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →